Search results
IDSA provides clinical practice guidelines and guidance documents for various infectious diseases, based on systematic reviews and expert consensus. Browse the alphabetical list of guidelines, view highlights, purchase reprints, or get the app.
- Training and Resources
IDSA Standards and Practice Guidelines Committee. Charge. To...
- Practice Guidelines APP
Latest guidelines and interactive point-of-care tools. Tools...
- Evaluation and Management Services
Dr. Timothy Sullivan, Vice Chair of IDSA’s Coding & Payment...
- Infection Prevention & Control
IDSA/SHEA: Primer on Healthcare Epidemiology, Infection...
- New Guidance
This guidance document provides recommendations to...
- Training and Resources
12 lip 2024 · This document provides recommendations for treatment of infections caused by ESBL-E, AmpC-E, CRE, DTR-P. aeruginosa, CRAB, and S. maltophilia. It replaces previous versions of the guidance and is published in Clinical Infectious Diseases.
Find out the latest updates and upcoming guidelines from IDSA and its endorsed societies on various infectious diseases topics. Browse the list of guidelines by publication date, journal, and status.
Find evidence-based recommendations for various infectious diseases from the Infectious Diseases Society of America (IDSA). Explore guidelines on topics such as aspergillosis, pneumonia, streptococcal infections, histoplasmosis, and more.
14 cze 2021 · This article provides updated recommendations for the management of CDI in adults based on evidence from systematic reviews. It covers the use of fidaxomicin and bezlotoxumab for initial and recurrent CDI episodes, and the challenges of diagnosis and implementation.
In March 2020, the Infectious Diseases Society of America (IDSA) formed a multidisciplinary guideline panel of infectious disease clinicians, pharmacists, and methodologists with varied areas of expertise to regularly review the evidence and make recommendations about the treatment and management of persons with COVID-19.
18 lip 2023 · This document provides treatment recommendations for infections caused by ESBL-E, AmpC-E, CRE, DTR-P. aeruginosa, CRAB, and S. maltophilia in the United States. It is based on a panel of experts' review of the literature, clinical experience, and opinion.
